{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T18:16:27Z","timestamp":1785780987187,"version":"3.56.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":324,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.14283\/jpad.2023.115","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T09:12:05Z","timestamp":1693991525000},"page":"886-894","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Genotypic Effects of the TOMM40'523 Variant and APOE on Longitudinal Cognitive Change over 4 Years: The TOMMORROW Study"],"prefix":"10.1016","volume":"10","author":[{"given":"H.","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.W.","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.A.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.L.","family":"Plassman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.A.","family":"Welsh-Bohmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.14283\/jpad.2023.115_bib1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","article-title":"Role of genes and environments for explaining Alzheimer disease","volume":"63","author":"Gatz","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.14283\/jpad.2023.115_bib2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer's disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.14283\/jpad.2023.115_bib3","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/s41588-021-00921-z","article-title":"A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease","volume":"53","author":"Wightman","year":"2021","journal-title":"Nat Genet"},{"key":"10.14283\/jpad.2023.115_bib4","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1038\/s41467-020-18534-1","article-title":"Risk prediction of late-onset Alzheimer's disease implies an oligogenic architecture","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat Commun"},{"key":"10.14283\/jpad.2023.115_bib5","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.14283\/jpad.2023.115_bib6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.14283\/jpad.2023.115_bib7","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1017\/S0033291709005492","article-title":"Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset","volume":"39","author":"van der Vlies","year":"2009","journal-title":"Psychol Med"},{"key":"10.14283\/jpad.2023.115_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1326-8-16","article-title":"ApoE4 induces Abeta42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice","volume":"8","author":"Liraz","year":"2013","journal-title":"Mol Neurodegener"},{"key":"10.14283\/jpad.2023.115_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13195-020-00712-4","article-title":"APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer's disease: a systematic review","volume":"12","author":"Emrani","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"10.14283\/jpad.2023.115_bib10","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/jnnp.73.6.672","article-title":"The apolipoprotein E epsilon 2 allele and decline in episodic memory","volume":"73","author":"Wilson","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.14283\/jpad.2023.115_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neurobiolaging.2015.10.031","article-title":"Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium","volume":"38","author":"Hohman","year":"2016","journal-title":"Neurobiol Aging"},{"key":"10.14283\/jpad.2023.115_bib12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neurobiolaging.2021.09.009","article-title":"Definitive roles of TOMM40-APOE-APOC1 variants in the Alzheimer's risk","volume":"110","author":"Kulminski","year":"2022","journal-title":"Neurobiol Aging"},{"key":"10.14283\/jpad.2023.115_bib13","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/archneurol.2011.155","article-title":"Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease","volume":"68","author":"Cruchaga","year":"2011","journal-title":"Arch Neurol"},{"key":"10.14283\/jpad.2023.115_bib14","doi-asserted-by":"crossref","first-page":"e0180356","DOI":"10.1371\/journal.pone.0180356","article-title":"APOE epsilon4-TOMM40' 523 haplotypes and the risk of Alzheimer's disease in older Caucasian and African Americans","volume":"12","author":"Yu","year":"2017","journal-title":"PLoS One"},{"key":"10.14283\/jpad.2023.115_bib15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fnhum.2013.00198","article-title":"The influence of APOE and TOMM40 polymorphisms on hippocampal volume and episodic memory in old age","volume":"7","author":"Ferencz","year":"2013","journal-title":"Front Hum Neurosci"},{"key":"10.14283\/jpad.2023.115_bib16","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/alz.12295","article-title":"TOMM40-APOE haplotypes are associated with cognitive decline in non-demented Blacks","volume":"17","author":"Deters","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2023.115_bib17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/tpj.2009.69","article-title":"A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease","volume":"10","author":"Roses","year":"2010","journal-title":"Pharmacogenomics J"},{"key":"10.14283\/jpad.2023.115_bib18","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.neurobiolaging.2015.03.004","article-title":"The effect of TOMM40 on spatial navigation in amnestic mild cognitive impairment","volume":"36","author":"Laczo","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.14283\/jpad.2023.115_bib19","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s40520-020-01661-6","article-title":"TOMM40 and APOE variants synergistically increase the risk of Alzheimer's disease in a Chinese population","volume":"33","author":"Zhu","year":"2021","journal-title":"Aging Clin Exp Res"},{"key":"10.14283\/jpad.2023.115_bib20","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1212\/NXG.0000000000000404","article-title":"Use of local genetic ancestry to assess TOMM40-523' and risk for Alzheimer disease","volume":"6","author":"Bussies","year":"2020","journal-title":"Neurol Genet"},{"key":"10.14283\/jpad.2023.115_bib21","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1212\/WNL.0000000000003614","article-title":"TOMM40\u2032523 variant and cognitive decline in older persons with APOE epsilon3\/3 genotype","volume":"88","author":"Yu","year":"2017","journal-title":"Neurology"},{"key":"10.14283\/jpad.2023.115_bib22","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3233\/JAD-190293","article-title":"TOMM40' 523 Associations with Baseline and Longitudinal Cognition in APOE varepsilon3 Homozygotes","volume":"70","author":"Watts","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.14283\/jpad.2023.115_bib23","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3233\/JAD-200338","article-title":"Alzheimer's Disease Susceptibility Gene Apolipoprotein E (APOE) and Blood Biomarkers in UK Biobank (N = 395,769)","volume":"76","author":"Ferguson","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.14283\/jpad.2023.115_bib24","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.trci.2018.06.009","article-title":"TOMMORROW neuropsychological battery: German language validation and normative study","volume":"4","author":"Romero","year":"2018","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.14283\/jpad.2023.115_bib25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.trci.2019.09.010","article-title":"The TOMMORROW study: Design of an Alzheimer's disease delay-of-onset clinical trial","volume":"5","author":"Burns","year":"2019","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.14283\/jpad.2023.115_bib26","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1474-4422(21)00043-0","article-title":"Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial","volume":"20","author":"Burns","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.14283\/jpad.2023.115_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-021-00200-y","article-title":"TOMM40 \u2018523' poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson's disease","volume":"7","author":"Bakeberg","year":"2021","journal-title":"Npj Parkinsons Dis"},{"key":"10.14283\/jpad.2023.115_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2018.01.015","article-title":"The effects of the TOMM40 poly-T alleles on Alzheimer's disease phenotypes","author":"Chiba-Falek","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2023.115_bib29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/jhg.2011.123","article-title":"Functional analysis of APOE locus genetic variation implicates regional enhancers in the regulation of both TOMM40 and APOE","volume":"57","author":"Bekris","year":"2012","journal-title":"J Hum Genet"},{"key":"10.14283\/jpad.2023.115_bib30","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.exger.2011.09.008","article-title":"Levels of cerebrospinal fluid neurofilament light protein in healthy elderly vary as a function of TOMM40 variants","volume":"47","author":"Bruno","year":"2012","journal-title":"Exp Gerontol"},{"key":"10.14283\/jpad.2023.115_bib31","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.neurobiolaging.2014.01.006","article-title":"Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936","volume":"35","author":"Lyall","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.14283\/jpad.2023.115_bib32","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1016\/j.bbadis.2017.07.031","article-title":"The biological foundation of the genetic association of TOMM40 with late-onset Alzheimer's disease","volume":"1863","author":"Zeitlow","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.14283\/jpad.2023.115_bib33","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1093\/emboj\/cdg229","article-title":"Tom40, the import channel of the mitochondrial outer membrane, plays an active role in sorting imported proteins","volume":"22","author":"Gabriel","year":"2003","journal-title":"EMBO J"},{"key":"10.14283\/jpad.2023.115_bib34","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1523\/JNEUROSCI.1469-06.2006","article-title":"Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction","volume":"26","author":"Devi","year":"2006","journal-title":"J Neurosci"},{"key":"10.14283\/jpad.2023.115_bib35","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jalz.2013.08.280","article-title":"The cis-regulatory effect of an Alzheimer's disease-associated poly-T locus on expression of TOMM40 and apolipoprotein E genes","volume":"10","author":"Linnertz","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2023.115_bib36","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/ajmg.b.30993","article-title":"APOE mRNA and protein expression in postmortem brain are modulated by an extended haplotype structure","volume":"153B","author":"Bekris","year":"2010","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.14283\/jpad.2023.115_bib37","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jalz.2012.06.009","article-title":"TOMM40 intron 6 poly-T length, age at onset, and neuropathology of AD in individuals with APOE epsilon3\/epsilon3","volume":"9","author":"Li","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2023.115_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/alz.12534","article-title":"Identifying differential regulatory control of APOE varepsilon4 on African versus European haplotypes as potential therapeutic targets","author":"Nuytemans","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2023.115_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-022-02925-6","article-title":"Amyloid-\u03b2 and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer's disease polygenic risk score","volume":"22","author":"Tomassen","year":"2022","journal-title":"BMC neurology"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724001791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724001791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T23:55:10Z","timestamp":1736466910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724001791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2274580724001791"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2023.115","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genotypic Effects of the TOMM40'523 Variant and APOE on Longitudinal Cognitive Change over 4 Years: The TOMMORROW Study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2023.115","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}